nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepenzolate—CHRM3—epilepsy syndrome	0.212	0.371	CbGaD
Mepenzolate—CHRM1—epilepsy syndrome	0.198	0.346	CbGaD
Mepenzolate—CHRM2—epilepsy syndrome	0.162	0.283	CbGaD
Mepenzolate—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0982	0.431	CrCrCtD
Mepenzolate—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0673	0.296	CrCrCtD
Mepenzolate—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0621	0.273	CrCrCtD
Mepenzolate—Diphemanil Methylsulfate—CHRM3—epilepsy syndrome	0.000254	0.0438	CrCbGaD
Mepenzolate—Insomnia—Fosphenytoin—epilepsy syndrome	0.000244	0.00192	CcSEcCtD
Mepenzolate—Vomiting—Rufinamide—epilepsy syndrome	0.000244	0.00192	CcSEcCtD
Mepenzolate—Constipation—Midazolam—epilepsy syndrome	0.000242	0.00191	CcSEcCtD
Mepenzolate—Dry mouth—Clonazepam—epilepsy syndrome	0.000241	0.0019	CcSEcCtD
Mepenzolate—Headache—Rufinamide—epilepsy syndrome	0.00024	0.00189	CcSEcCtD
Mepenzolate—Somnolence—Fosphenytoin—epilepsy syndrome	0.00024	0.00189	CcSEcCtD
Mepenzolate—Dry mouth—Phenytoin—epilepsy syndrome	0.000239	0.00189	CcSEcCtD
Mepenzolate—Tachycardia—Zonisamide—epilepsy syndrome	0.000239	0.00189	CcSEcCtD
Mepenzolate—Constipation—Levetiracetam—epilepsy syndrome	0.000239	0.00188	CcSEcCtD
Mepenzolate—Feeling abnormal—Propofol—epilepsy syndrome	0.000238	0.00188	CcSEcCtD
Mepenzolate—Confusional state—Clonazepam—epilepsy syndrome	0.000238	0.00188	CcSEcCtD
Mepenzolate—Dry mouth—Oxcarbazepine—epilepsy syndrome	0.000238	0.00188	CcSEcCtD
Mepenzolate—Dizziness—Lacosamide—epilepsy syndrome	0.000238	0.00188	CcSEcCtD
Mepenzolate—Insomnia—Vigabatrin—epilepsy syndrome	0.000238	0.00187	CcSEcCtD
Mepenzolate—Diphemanil Methylsulfate—CHRM1—epilepsy syndrome	0.000237	0.0409	CrCbGaD
Mepenzolate—Confusional state—Phenytoin—epilepsy syndrome	0.000236	0.00187	CcSEcCtD
Mepenzolate—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000236	0.00186	CcSEcCtD
Mepenzolate—Confusional state—Oxcarbazepine—epilepsy syndrome	0.000235	0.00186	CcSEcCtD
Mepenzolate—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000235	0.00185	CcSEcCtD
Mepenzolate—Palpitations—Lamotrigine—epilepsy syndrome	0.000234	0.00185	CcSEcCtD
Mepenzolate—Insomnia—Diazepam—epilepsy syndrome	0.000234	0.00185	CcSEcCtD
Mepenzolate—Somnolence—Vigabatrin—epilepsy syndrome	0.000234	0.00184	CcSEcCtD
Mepenzolate—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000233	0.00184	CcSEcCtD
Mepenzolate—Feeling abnormal—Midazolam—epilepsy syndrome	0.000233	0.00184	CcSEcCtD
Mepenzolate—Urinary retention—Topiramate—epilepsy syndrome	0.000232	0.00183	CcSEcCtD
Mepenzolate—Nausea—Phenobarbital—epilepsy syndrome	0.000232	0.00183	CcSEcCtD
Mepenzolate—Erectile dysfunction—Gabapentin—epilepsy syndrome	0.000231	0.00182	CcSEcCtD
Mepenzolate—Dizziness—Clobazam—epilepsy syndrome	0.000231	0.00182	CcSEcCtD
Mepenzolate—Tachycardia—Clonazepam—epilepsy syndrome	0.00023	0.00182	CcSEcCtD
Mepenzolate—Constipation—Fosphenytoin—epilepsy syndrome	0.00023	0.00182	CcSEcCtD
Mepenzolate—Feeling abnormal—Levetiracetam—epilepsy syndrome	0.00023	0.00182	CcSEcCtD
Mepenzolate—Somnolence—Diazepam—epilepsy syndrome	0.00023	0.00181	CcSEcCtD
Mepenzolate—Urticaria—Propofol—epilepsy syndrome	0.00023	0.00181	CcSEcCtD
Mepenzolate—Tachycardia—Phenytoin—epilepsy syndrome	0.000229	0.00181	CcSEcCtD
Mepenzolate—Vomiting—Lacosamide—epilepsy syndrome	0.000229	0.0018	CcSEcCtD
Mepenzolate—Dry mouth—Carbamazepine—epilepsy syndrome	0.000228	0.0018	CcSEcCtD
Mepenzolate—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000228	0.0018	CcSEcCtD
Mepenzolate—Nausea—Rufinamide—epilepsy syndrome	0.000228	0.0018	CcSEcCtD
Mepenzolate—Insomnia—Felbamate—epilepsy syndrome	0.000226	0.00179	CcSEcCtD
Mepenzolate—Confusional state—Carbamazepine—epilepsy syndrome	0.000226	0.00178	CcSEcCtD
Mepenzolate—Headache—Lacosamide—epilepsy syndrome	0.000225	0.00178	CcSEcCtD
Mepenzolate—Constipation—Vigabatrin—epilepsy syndrome	0.000225	0.00177	CcSEcCtD
Mepenzolate—Urticaria—Midazolam—epilepsy syndrome	0.000225	0.00177	CcSEcCtD
Mepenzolate—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000224	0.00177	CcSEcCtD
Mepenzolate—Drowsiness—Gabapentin—epilepsy syndrome	0.000223	0.00176	CcSEcCtD
Mepenzolate—Asthenia—Acetazolamide—epilepsy syndrome	0.000223	0.00176	CcSEcCtD
Mepenzolate—Somnolence—Felbamate—epilepsy syndrome	0.000223	0.00176	CcSEcCtD
Mepenzolate—Difenoxin—OPRM1—epilepsy syndrome	0.000222	0.0384	CrCbGaD
Mepenzolate—Feeling abnormal—Fosphenytoin—epilepsy syndrome	0.000222	0.00175	CcSEcCtD
Mepenzolate—Vomiting—Clobazam—epilepsy syndrome	0.000222	0.00175	CcSEcCtD
Mepenzolate—Insomnia—Zonisamide—epilepsy syndrome	0.000222	0.00175	CcSEcCtD
Mepenzolate—Constipation—Diazepam—epilepsy syndrome	0.000221	0.00174	CcSEcCtD
Mepenzolate—Dry mouth—Lamotrigine—epilepsy syndrome	0.000221	0.00174	CcSEcCtD
Mepenzolate—Headache—Clobazam—epilepsy syndrome	0.000219	0.00173	CcSEcCtD
Mepenzolate—Tachycardia—Carbamazepine—epilepsy syndrome	0.000219	0.00172	CcSEcCtD
Mepenzolate—Confusional state—Lamotrigine—epilepsy syndrome	0.000218	0.00172	CcSEcCtD
Mepenzolate—Somnolence—Zonisamide—epilepsy syndrome	0.000218	0.00172	CcSEcCtD
Mepenzolate—Loperamide—CACNA1A—epilepsy syndrome	0.000218	0.0375	CrCbGaD
Mepenzolate—Feeling abnormal—Vigabatrin—epilepsy syndrome	0.000216	0.00171	CcSEcCtD
Mepenzolate—Urticaria—Fosphenytoin—epilepsy syndrome	0.000214	0.00169	CcSEcCtD
Mepenzolate—Constipation—Felbamate—epilepsy syndrome	0.000214	0.00169	CcSEcCtD
Mepenzolate—Nausea—Lacosamide—epilepsy syndrome	0.000214	0.00169	CcSEcCtD
Mepenzolate—Insomnia—Clonazepam—epilepsy syndrome	0.000214	0.00169	CcSEcCtD
Mepenzolate—Feeling abnormal—Diazepam—epilepsy syndrome	0.000213	0.00168	CcSEcCtD
Mepenzolate—Abdominal distension—Topiramate—epilepsy syndrome	0.000212	0.00168	CcSEcCtD
Mepenzolate—Insomnia—Phenytoin—epilepsy syndrome	0.000212	0.00167	CcSEcCtD
Mepenzolate—Tachycardia—Lamotrigine—epilepsy syndrome	0.000211	0.00167	CcSEcCtD
Mepenzolate—Insomnia—Oxcarbazepine—epilepsy syndrome	0.000211	0.00166	CcSEcCtD
Mepenzolate—Somnolence—Clonazepam—epilepsy syndrome	0.00021	0.00166	CcSEcCtD
Mepenzolate—Constipation—Zonisamide—epilepsy syndrome	0.00021	0.00165	CcSEcCtD
Mepenzolate—Urticaria—Vigabatrin—epilepsy syndrome	0.000209	0.00165	CcSEcCtD
Mepenzolate—Somnolence—Phenytoin—epilepsy syndrome	0.000209	0.00165	CcSEcCtD
Mepenzolate—Hypersensitivity—Midazolam—epilepsy syndrome	0.000208	0.00164	CcSEcCtD
Mepenzolate—Somnolence—Oxcarbazepine—epilepsy syndrome	0.000207	0.00164	CcSEcCtD
Mepenzolate—Nausea—Clobazam—epilepsy syndrome	0.000207	0.00164	CcSEcCtD
Mepenzolate—Asthenia—Propofol—epilepsy syndrome	0.000207	0.00164	CcSEcCtD
Mepenzolate—Tension—Valproic Acid—epilepsy syndrome	0.000207	0.00163	CcSEcCtD
Mepenzolate—Feeling abnormal—Felbamate—epilepsy syndrome	0.000206	0.00163	CcSEcCtD
Mepenzolate—Dizziness—Acetazolamide—epilepsy syndrome	0.000206	0.00162	CcSEcCtD
Mepenzolate—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000206	0.00162	CcSEcCtD
Mepenzolate—Urticaria—Diazepam—epilepsy syndrome	0.000205	0.00162	CcSEcCtD
Mepenzolate—Aclidinium—CHRM3—epilepsy syndrome	0.000205	0.0353	CrCbGaD
Mepenzolate—Diphenoxylate—OPRD1—epilepsy syndrome	0.000205	0.0353	CrCbGaD
Mepenzolate—Nervousness—Valproic Acid—epilepsy syndrome	0.000205	0.00161	CcSEcCtD
Mepenzolate—Asthenia—Midazolam—epilepsy syndrome	0.000203	0.0016	CcSEcCtD
Mepenzolate—Insomnia—Carbamazepine—epilepsy syndrome	0.000202	0.0016	CcSEcCtD
Mepenzolate—Constipation—Clonazepam—epilepsy syndrome	0.000202	0.00159	CcSEcCtD
Mepenzolate—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000202	0.00159	CcSEcCtD
Mepenzolate—Constipation—Phenytoin—epilepsy syndrome	0.000201	0.00158	CcSEcCtD
Mepenzolate—Asthenia—Levetiracetam—epilepsy syndrome	0.0002	0.00158	CcSEcCtD
Mepenzolate—Constipation—Oxcarbazepine—epilepsy syndrome	0.0002	0.00157	CcSEcCtD
Mepenzolate—Somnolence—Carbamazepine—epilepsy syndrome	0.000199	0.00157	CcSEcCtD
Mepenzolate—Urticaria—Felbamate—epilepsy syndrome	0.000199	0.00157	CcSEcCtD
Mepenzolate—Vision blurred—Valproic Acid—epilepsy syndrome	0.000199	0.00157	CcSEcCtD
Mepenzolate—Vomiting—Acetazolamide—epilepsy syndrome	0.000198	0.00156	CcSEcCtD
Mepenzolate—Insomnia—Lamotrigine—epilepsy syndrome	0.000196	0.00154	CcSEcCtD
Mepenzolate—Headache—Acetazolamide—epilepsy syndrome	0.000195	0.00154	CcSEcCtD
Mepenzolate—Urticaria—Zonisamide—epilepsy syndrome	0.000195	0.00154	CcSEcCtD
Mepenzolate—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000195	0.00154	CcSEcCtD
Mepenzolate—Erectile dysfunction—Topiramate—epilepsy syndrome	0.000194	0.00153	CcSEcCtD
Mepenzolate—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000194	0.00153	CcSEcCtD
Mepenzolate—Asthenia—Fosphenytoin—epilepsy syndrome	0.000193	0.00153	CcSEcCtD
Mepenzolate—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000193	0.00153	CcSEcCtD
Mepenzolate—Somnolence—Lamotrigine—epilepsy syndrome	0.000192	0.00152	CcSEcCtD
Mepenzolate—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000192	0.00152	CcSEcCtD
Mepenzolate—Constipation—Carbamazepine—epilepsy syndrome	0.000191	0.00151	CcSEcCtD
Mepenzolate—Dizziness—Propofol—epilepsy syndrome	0.000191	0.00151	CcSEcCtD
Mepenzolate—Aclidinium—CHRM1—epilepsy syndrome	0.000191	0.0329	CrCbGaD
Mepenzolate—Hypersensitivity—Diazepam—epilepsy syndrome	0.000191	0.0015	CcSEcCtD
Mepenzolate—Asthenia—Vigabatrin—epilepsy syndrome	0.000188	0.00149	CcSEcCtD
Mepenzolate—Urticaria—Clonazepam—epilepsy syndrome	0.000188	0.00148	CcSEcCtD
Mepenzolate—Dizziness—Midazolam—epilepsy syndrome	0.000187	0.00148	CcSEcCtD
Mepenzolate—Tension—Pregabalin—epilepsy syndrome	0.000187	0.00147	CcSEcCtD
Mepenzolate—Urticaria—Phenytoin—epilepsy syndrome	0.000186	0.00147	CcSEcCtD
Mepenzolate—Palpitations—Valproic Acid—epilepsy syndrome	0.000186	0.00147	CcSEcCtD
Mepenzolate—Asthenia—Diazepam—epilepsy syndrome	0.000186	0.00146	CcSEcCtD
Mepenzolate—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000185	0.00146	CcSEcCtD
Mepenzolate—Constipation—Lamotrigine—epilepsy syndrome	0.000185	0.00146	CcSEcCtD
Mepenzolate—Nervousness—Pregabalin—epilepsy syndrome	0.000185	0.00146	CcSEcCtD
Mepenzolate—Nausea—Acetazolamide—epilepsy syndrome	0.000185	0.00146	CcSEcCtD
Mepenzolate—Dizziness—Levetiracetam—epilepsy syndrome	0.000185	0.00146	CcSEcCtD
Mepenzolate—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000184	0.00146	CcSEcCtD
Mepenzolate—Vomiting—Propofol—epilepsy syndrome	0.000184	0.00145	CcSEcCtD
Mepenzolate—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000181	0.0313	CrCbGaD
Mepenzolate—Headache—Propofol—epilepsy syndrome	0.000181	0.00143	CcSEcCtD
Mepenzolate—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000181	0.00142	CcSEcCtD
Mepenzolate—Vomiting—Midazolam—epilepsy syndrome	0.00018	0.00142	CcSEcCtD
Mepenzolate—Asthenia—Felbamate—epilepsy syndrome	0.00018	0.00142	CcSEcCtD
Mepenzolate—Vision blurred—Pregabalin—epilepsy syndrome	0.000179	0.00142	CcSEcCtD
Mepenzolate—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000178	0.00141	CcSEcCtD
Mepenzolate—Dizziness—Fosphenytoin—epilepsy syndrome	0.000178	0.00141	CcSEcCtD
Mepenzolate—Urticaria—Carbamazepine—epilepsy syndrome	0.000178	0.0014	CcSEcCtD
Mepenzolate—Vomiting—Levetiracetam—epilepsy syndrome	0.000178	0.0014	CcSEcCtD
Mepenzolate—Headache—Midazolam—epilepsy syndrome	0.000177	0.0014	CcSEcCtD
Mepenzolate—Asthenia—Zonisamide—epilepsy syndrome	0.000176	0.00139	CcSEcCtD
Mepenzolate—Dry mouth—Valproic Acid—epilepsy syndrome	0.000175	0.00138	CcSEcCtD
Mepenzolate—Headache—Levetiracetam—epilepsy syndrome	0.000175	0.00138	CcSEcCtD
Mepenzolate—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000174	0.00137	CcSEcCtD
Mepenzolate—Dizziness—Vigabatrin—epilepsy syndrome	0.000174	0.00137	CcSEcCtD
Mepenzolate—Confusional state—Valproic Acid—epilepsy syndrome	0.000173	0.00137	CcSEcCtD
Mepenzolate—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000173	0.00136	CcSEcCtD
Mepenzolate—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000172	0.00136	CcSEcCtD
Mepenzolate—Urticaria—Lamotrigine—epilepsy syndrome	0.000172	0.00136	CcSEcCtD
Mepenzolate—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000172	0.00136	CcSEcCtD
Mepenzolate—Nausea—Propofol—epilepsy syndrome	0.000172	0.00135	CcSEcCtD
Mepenzolate—Tension—Gabapentin—epilepsy syndrome	0.000171	0.00135	CcSEcCtD
Mepenzolate—Vomiting—Fosphenytoin—epilepsy syndrome	0.000171	0.00135	CcSEcCtD
Mepenzolate—Dizziness—Diazepam—epilepsy syndrome	0.000171	0.00135	CcSEcCtD
Mepenzolate—Nervousness—Gabapentin—epilepsy syndrome	0.00017	0.00134	CcSEcCtD
Mepenzolate—Asthenia—Clonazepam—epilepsy syndrome	0.000169	0.00134	CcSEcCtD
Mepenzolate—Headache—Fosphenytoin—epilepsy syndrome	0.000169	0.00133	CcSEcCtD
Mepenzolate—Palpitations—Pregabalin—epilepsy syndrome	0.000168	0.00133	CcSEcCtD
Mepenzolate—Asthenia—Phenytoin—epilepsy syndrome	0.000168	0.00133	CcSEcCtD
Mepenzolate—Nausea—Midazolam—epilepsy syndrome	0.000168	0.00133	CcSEcCtD
Mepenzolate—Tachycardia—Valproic Acid—epilepsy syndrome	0.000168	0.00132	CcSEcCtD
Mepenzolate—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000167	0.00132	CcSEcCtD
Mepenzolate—Vomiting—Vigabatrin—epilepsy syndrome	0.000167	0.00132	CcSEcCtD
Mepenzolate—Clidinium—CHRM3—epilepsy syndrome	0.000167	0.0288	CrCbGaD
Mepenzolate—Nausea—Levetiracetam—epilepsy syndrome	0.000166	0.00131	CcSEcCtD
Mepenzolate—Dizziness—Felbamate—epilepsy syndrome	0.000166	0.00131	CcSEcCtD
Mepenzolate—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000165	0.0013	CcSEcCtD
Mepenzolate—Vision blurred—Gabapentin—epilepsy syndrome	0.000165	0.0013	CcSEcCtD
Mepenzolate—Headache—Vigabatrin—epilepsy syndrome	0.000165	0.0013	CcSEcCtD
Mepenzolate—Vomiting—Diazepam—epilepsy syndrome	0.000164	0.0013	CcSEcCtD
Mepenzolate—Dizziness—Zonisamide—epilepsy syndrome	0.000162	0.00128	CcSEcCtD
Mepenzolate—Headache—Diazepam—epilepsy syndrome	0.000162	0.00128	CcSEcCtD
Mepenzolate—Trospium—CHRM3—epilepsy syndrome	0.000161	0.0277	CrCbGaD
Mepenzolate—Asthenia—Carbamazepine—epilepsy syndrome	0.000161	0.00127	CcSEcCtD
Mepenzolate—Fexofenadine—SLCO1A2—epilepsy syndrome	0.00016	0.0277	CrCbGaD
Mepenzolate—Nausea—Fosphenytoin—epilepsy syndrome	0.00016	0.00126	CcSEcCtD
Mepenzolate—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000159	0.00126	CcSEcCtD
Mepenzolate—Vomiting—Felbamate—epilepsy syndrome	0.000159	0.00126	CcSEcCtD
Mepenzolate—Dry mouth—Pregabalin—epilepsy syndrome	0.000159	0.00125	CcSEcCtD
Mepenzolate—Headache—Felbamate—epilepsy syndrome	0.000157	0.00124	CcSEcCtD
Mepenzolate—Confusional state—Pregabalin—epilepsy syndrome	0.000157	0.00124	CcSEcCtD
Mepenzolate—Diphenoxylate—OPRM1—epilepsy syndrome	0.000157	0.027	CrCbGaD
Mepenzolate—Dizziness—Clonazepam—epilepsy syndrome	0.000156	0.00123	CcSEcCtD
Mepenzolate—Nausea—Vigabatrin—epilepsy syndrome	0.000156	0.00123	CcSEcCtD
Mepenzolate—Aclidinium—CHRM2—epilepsy syndrome	0.000156	0.0269	CrCbGaD
Mepenzolate—Vomiting—Zonisamide—epilepsy syndrome	0.000156	0.00123	CcSEcCtD
Mepenzolate—Clidinium—CHRM1—epilepsy syndrome	0.000156	0.0269	CrCbGaD
Mepenzolate—Insomnia—Valproic Acid—epilepsy syndrome	0.000156	0.00123	CcSEcCtD
Mepenzolate—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000155	0.00123	CcSEcCtD
Mepenzolate—Asthenia—Lamotrigine—epilepsy syndrome	0.000155	0.00122	CcSEcCtD
Mepenzolate—Dizziness—Phenytoin—epilepsy syndrome	0.000155	0.00122	CcSEcCtD
Mepenzolate—Palpitations—Gabapentin—epilepsy syndrome	0.000154	0.00122	CcSEcCtD
Mepenzolate—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000154	0.00122	CcSEcCtD
Mepenzolate—Nausea—Diazepam—epilepsy syndrome	0.000154	0.00121	CcSEcCtD
Mepenzolate—Headache—Zonisamide—epilepsy syndrome	0.000153	0.00121	CcSEcCtD
Mepenzolate—Somnolence—Valproic Acid—epilepsy syndrome	0.000153	0.00121	CcSEcCtD
Mepenzolate—Tachycardia—Pregabalin—epilepsy syndrome	0.000152	0.0012	CcSEcCtD
Mepenzolate—Loperamide—POMC—epilepsy syndrome	0.000151	0.026	CrCbGaD
Mepenzolate—Vomiting—Clonazepam—epilepsy syndrome	0.00015	0.00118	CcSEcCtD
Mepenzolate—Trospium—CHRM1—epilepsy syndrome	0.00015	0.0258	CrCbGaD
Mepenzolate—Vomiting—Phenytoin—epilepsy syndrome	0.000149	0.00118	CcSEcCtD
Mepenzolate—Nausea—Felbamate—epilepsy syndrome	0.000149	0.00117	CcSEcCtD
Mepenzolate—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000148	0.00117	CcSEcCtD
Mepenzolate—Dizziness—Carbamazepine—epilepsy syndrome	0.000148	0.00117	CcSEcCtD
Mepenzolate—Headache—Clonazepam—epilepsy syndrome	0.000148	0.00117	CcSEcCtD
Mepenzolate—Constipation—Valproic Acid—epilepsy syndrome	0.000147	0.00116	CcSEcCtD
Mepenzolate—Glycopyrrolate—CHRM3—epilepsy syndrome	0.000147	0.0253	CrCbGaD
Mepenzolate—Headache—Phenytoin—epilepsy syndrome	0.000147	0.00116	CcSEcCtD
Mepenzolate—Headache—Oxcarbazepine—epilepsy syndrome	0.000146	0.00115	CcSEcCtD
Mepenzolate—Nausea—Zonisamide—epilepsy syndrome	0.000146	0.00115	CcSEcCtD
Mepenzolate—Dry mouth—Gabapentin—epilepsy syndrome	0.000145	0.00115	CcSEcCtD
Mepenzolate—Tension—Topiramate—epilepsy syndrome	0.000144	0.00114	CcSEcCtD
Mepenzolate—Confusional state—Gabapentin—epilepsy syndrome	0.000144	0.00113	CcSEcCtD
Mepenzolate—Dizziness—Lamotrigine—epilepsy syndrome	0.000143	0.00113	CcSEcCtD
Mepenzolate—Nervousness—Topiramate—epilepsy syndrome	0.000143	0.00113	CcSEcCtD
Mepenzolate—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000143	0.00112	CcSEcCtD
Mepenzolate—Vomiting—Carbamazepine—epilepsy syndrome	0.000142	0.00112	CcSEcCtD
Mepenzolate—Isopropamide—CHRM3—epilepsy syndrome	0.000142	0.0245	CrCbGaD
Mepenzolate—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000142	0.00112	CcSEcCtD
Mepenzolate—Insomnia—Pregabalin—epilepsy syndrome	0.000141	0.00111	CcSEcCtD
Mepenzolate—Nausea—Clonazepam—epilepsy syndrome	0.00014	0.00111	CcSEcCtD
Mepenzolate—Headache—Carbamazepine—epilepsy syndrome	0.00014	0.00111	CcSEcCtD
Mepenzolate—Nausea—Phenytoin—epilepsy syndrome	0.000139	0.0011	CcSEcCtD
Mepenzolate—Tachycardia—Gabapentin—epilepsy syndrome	0.000139	0.0011	CcSEcCtD
Mepenzolate—Nausea—Oxcarbazepine—epilepsy syndrome	0.000139	0.00109	CcSEcCtD
Mepenzolate—Vision blurred—Topiramate—epilepsy syndrome	0.000138	0.00109	CcSEcCtD
Mepenzolate—Somnolence—Pregabalin—epilepsy syndrome	0.000138	0.00109	CcSEcCtD
Mepenzolate—Vomiting—Lamotrigine—epilepsy syndrome	0.000138	0.00109	CcSEcCtD
Mepenzolate—Glycopyrrolate—CHRM1—epilepsy syndrome	0.000137	0.0236	CrCbGaD
Mepenzolate—Urticaria—Valproic Acid—epilepsy syndrome	0.000137	0.00108	CcSEcCtD
Mepenzolate—Headache—Lamotrigine—epilepsy syndrome	0.000136	0.00107	CcSEcCtD
Mepenzolate—Nausea—Carbamazepine—epilepsy syndrome	0.000133	0.00105	CcSEcCtD
Mepenzolate—Constipation—Pregabalin—epilepsy syndrome	0.000133	0.00105	CcSEcCtD
Mepenzolate—Isopropamide—CHRM1—epilepsy syndrome	0.000132	0.0228	CrCbGaD
Mepenzolate—Aclidinium—BCHE—epilepsy syndrome	0.00013	0.0224	CrCbGaD
Mepenzolate—Palpitations—Topiramate—epilepsy syndrome	0.00013	0.00102	CcSEcCtD
Mepenzolate—Insomnia—Gabapentin—epilepsy syndrome	0.000129	0.00102	CcSEcCtD
Mepenzolate—Nausea—Lamotrigine—epilepsy syndrome	0.000129	0.00101	CcSEcCtD
Mepenzolate—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000128	0.00101	CcSEcCtD
Mepenzolate—Somnolence—Gabapentin—epilepsy syndrome	0.000127	0.001	CcSEcCtD
Mepenzolate—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000127	0.001	CcSEcCtD
Mepenzolate—Urticaria—Pregabalin—epilepsy syndrome	0.000123	0.000974	CcSEcCtD
Mepenzolate—Asthenia—Valproic Acid—epilepsy syndrome	0.000123	0.000973	CcSEcCtD
Mepenzolate—Trospium—CHRM2—epilepsy syndrome	0.000122	0.0211	CrCbGaD
Mepenzolate—Dry mouth—Topiramate—epilepsy syndrome	0.000122	0.000965	CcSEcCtD
Mepenzolate—Constipation—Gabapentin—epilepsy syndrome	0.000122	0.000962	CcSEcCtD
Mepenzolate—Confusional state—Topiramate—epilepsy syndrome	0.000121	0.000954	CcSEcCtD
Mepenzolate—Diphenidol—CHRM3—epilepsy syndrome	0.000118	0.0203	CrCbGaD
Mepenzolate—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000117	0.000927	CcSEcCtD
Mepenzolate—Tachycardia—Topiramate—epilepsy syndrome	0.000117	0.000923	CcSEcCtD
Mepenzolate—Darifenacin—CHRM3—epilepsy syndrome	0.000117	0.0201	CrCbGaD
Mepenzolate—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000115	0.000904	CcSEcCtD
Mepenzolate—Dizziness—Valproic Acid—epilepsy syndrome	0.000114	0.000897	CcSEcCtD
Mepenzolate—Urticaria—Gabapentin—epilepsy syndrome	0.000113	0.000893	CcSEcCtD
Mepenzolate—Glycopyrrolate—CHRM2—epilepsy syndrome	0.000112	0.0193	CrCbGaD
Mepenzolate—Asthenia—Pregabalin—epilepsy syndrome	0.000112	0.00088	CcSEcCtD
Mepenzolate—Diphenidol—CHRM1—epilepsy syndrome	0.00011	0.0189	CrCbGaD
Mepenzolate—Vomiting—Valproic Acid—epilepsy syndrome	0.000109	0.000863	CcSEcCtD
Mepenzolate—Darifenacin—CHRM1—epilepsy syndrome	0.000109	0.0188	CrCbGaD
Mepenzolate—Insomnia—Topiramate—epilepsy syndrome	0.000108	0.000856	CcSEcCtD
Mepenzolate—Headache—Valproic Acid—epilepsy syndrome	0.000108	0.00085	CcSEcCtD
Mepenzolate—Somnolence—Topiramate—epilepsy syndrome	0.000107	0.000841	CcSEcCtD
Mepenzolate—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000105	0.000829	CcSEcCtD
Mepenzolate—Dizziness—Pregabalin—epilepsy syndrome	0.000103	0.000811	CcSEcCtD
Mepenzolate—Constipation—Topiramate—epilepsy syndrome	0.000103	0.000809	CcSEcCtD
Mepenzolate—Asthenia—Gabapentin—epilepsy syndrome	0.000102	0.000807	CcSEcCtD
Mepenzolate—Nausea—Valproic Acid—epilepsy syndrome	0.000102	0.000806	CcSEcCtD
Mepenzolate—Vomiting—Pregabalin—epilepsy syndrome	9.88e-05	0.00078	CcSEcCtD
Mepenzolate—Feeling abnormal—Topiramate—epilepsy syndrome	9.88e-05	0.00078	CcSEcCtD
Mepenzolate—Headache—Pregabalin—epilepsy syndrome	9.74e-05	0.000768	CcSEcCtD
Mepenzolate—Benzatropine—CHRM1—epilepsy syndrome	9.66e-05	0.0167	CrCbGaD
Mepenzolate—Urticaria—Topiramate—epilepsy syndrome	9.53e-05	0.000752	CcSEcCtD
Mepenzolate—Dizziness—Gabapentin—epilepsy syndrome	9.43e-05	0.000744	CcSEcCtD
Mepenzolate—Nausea—Pregabalin—epilepsy syndrome	9.23e-05	0.000729	CcSEcCtD
Mepenzolate—Vomiting—Gabapentin—epilepsy syndrome	9.06e-05	0.000715	CcSEcCtD
Mepenzolate—Diphenidol—CHRM2—epilepsy syndrome	8.96e-05	0.0154	CrCbGaD
Mepenzolate—Headache—Gabapentin—epilepsy syndrome	8.93e-05	0.000705	CcSEcCtD
Mepenzolate—Dextropropoxyphene—OPRD1—epilepsy syndrome	8.91e-05	0.0154	CrCbGaD
Mepenzolate—Darifenacin—CHRM2—epilepsy syndrome	8.88e-05	0.0153	CrCbGaD
Mepenzolate—Hypersensitivity—Topiramate—epilepsy syndrome	8.83e-05	0.000697	CcSEcCtD
Mepenzolate—Fentanyl—OPRD1—epilepsy syndrome	8.82e-05	0.0152	CrCbGaD
Mepenzolate—Asthenia—Topiramate—epilepsy syndrome	8.6e-05	0.000679	CcSEcCtD
Mepenzolate—Loperamide—OPRD1—epilepsy syndrome	8.49e-05	0.0146	CrCbGaD
Mepenzolate—Nausea—Gabapentin—epilepsy syndrome	8.47e-05	0.000668	CcSEcCtD
Mepenzolate—Dizziness—Topiramate—epilepsy syndrome	7.93e-05	0.000626	CcSEcCtD
Mepenzolate—Levomethadyl Acetate—OPRM1—epilepsy syndrome	7.89e-05	0.0136	CrCbGaD
Mepenzolate—Benzatropine—CHRM2—epilepsy syndrome	7.89e-05	0.0136	CrCbGaD
Mepenzolate—Vomiting—Topiramate—epilepsy syndrome	7.62e-05	0.000602	CcSEcCtD
Mepenzolate—Headache—Topiramate—epilepsy syndrome	7.51e-05	0.000593	CcSEcCtD
Mepenzolate—Nausea—Topiramate—epilepsy syndrome	7.12e-05	0.000562	CcSEcCtD
Mepenzolate—Dextropropoxyphene—OPRM1—epilepsy syndrome	6.82e-05	0.0118	CrCbGaD
Mepenzolate—Fentanyl—OPRM1—epilepsy syndrome	6.75e-05	0.0116	CrCbGaD
Mepenzolate—Loperamide—OPRM1—epilepsy syndrome	6.5e-05	0.0112	CrCbGaD
Mepenzolate—Methadone—OPRD1—epilepsy syndrome	6.05e-05	0.0104	CrCbGaD
Mepenzolate—Clemastine—CYP2D6—epilepsy syndrome	5.71e-05	0.00984	CrCbGaD
Mepenzolate—Trospium—CYP2D6—epilepsy syndrome	5.6e-05	0.00966	CrCbGaD
Mepenzolate—Benzatropine—CYP2C19—epilepsy syndrome	4.87e-05	0.00839	CrCbGaD
Mepenzolate—Methadone—OPRM1—epilepsy syndrome	4.63e-05	0.00798	CrCbGaD
Mepenzolate—Darifenacin—CYP2D6—epilepsy syndrome	4.07e-05	0.00701	CrCbGaD
Mepenzolate—Fexofenadine—CYP2D6—epilepsy syndrome	3.95e-05	0.00682	CrCbGaD
Mepenzolate—Benzatropine—CYP2D6—epilepsy syndrome	3.61e-05	0.00622	CrCbGaD
Mepenzolate—Fexofenadine—ABCB1—epilepsy syndrome	2.82e-05	0.00487	CrCbGaD
Mepenzolate—Dextropropoxyphene—CYP2D6—epilepsy syndrome	2.64e-05	0.00456	CrCbGaD
Mepenzolate—Loperamide—CYP2D6—epilepsy syndrome	2.52e-05	0.00434	CrCbGaD
Mepenzolate—Methadone—CYP2C19—epilepsy syndrome	2.42e-05	0.00417	CrCbGaD
Mepenzolate—Fentanyl—ABCB1—epilepsy syndrome	1.87e-05	0.00322	CrCbGaD
Mepenzolate—Loperamide—ABCB1—epilepsy syndrome	1.8e-05	0.0031	CrCbGaD
Mepenzolate—Methadone—CYP2D6—epilepsy syndrome	1.79e-05	0.00309	CrCbGaD
Mepenzolate—CHRM3—Metabolism—ABCG2—epilepsy syndrome	1.3e-05	0.000193	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	1.29e-05	0.000192	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.28e-05	0.00019	CbGpPWpGaD
Mepenzolate—Methadone—ABCB1—epilepsy syndrome	1.28e-05	0.00221	CrCbGaD
Mepenzolate—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.28e-05	0.00019	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	1.27e-05	0.000188	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	1.27e-05	0.000188	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	1.26e-05	0.000187	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.26e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CHRM2—epilepsy syndrome	1.26e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.26e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	1.25e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.25e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.25e-05	0.000186	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	1.24e-05	0.000184	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	1.24e-05	0.000184	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	1.23e-05	0.000182	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	1.22e-05	0.000182	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	1.22e-05	0.000181	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	1.22e-05	0.000181	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	1.21e-05	0.00018	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	1.21e-05	0.000179	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	1.19e-05	0.000176	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	1.19e-05	0.000176	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	1.17e-05	0.000174	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	1.17e-05	0.000174	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	1.17e-05	0.000173	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	1.16e-05	0.000172	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	1.15e-05	0.000171	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	1.15e-05	0.000171	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	1.14e-05	0.000169	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	1.14e-05	0.000168	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	1.11e-05	0.000165	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	1.11e-05	0.000165	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	1.1e-05	0.000163	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	1.09e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.09e-05	0.000162	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.09e-05	0.000161	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	1.08e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—BCHE—epilepsy syndrome	1.08e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	1.08e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	1.08e-05	0.00016	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	1.06e-05	0.000158	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.06e-05	0.000158	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	1.06e-05	0.000157	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	1.06e-05	0.000157	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	1.05e-05	0.000156	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	1.05e-05	0.000156	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	1.03e-05	0.000153	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	1.03e-05	0.000153	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	1.03e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	1.02e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	1.02e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	1.02e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	1.02e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	1.02e-05	0.000152	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	1.02e-05	0.000151	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PLCB1—epilepsy syndrome	1.02e-05	0.000151	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—TH—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	1.01e-05	0.00015	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	9.98e-06	0.000148	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	9.9e-06	0.000147	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	9.87e-06	0.000146	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	9.77e-06	0.000145	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.56e-06	0.000142	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	9.53e-06	0.000141	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	9.53e-06	0.000141	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.53e-06	0.000141	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	9.5e-06	0.000141	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	9.5e-06	0.000141	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.43e-06	0.00014	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	9.41e-06	0.00014	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	9.41e-06	0.00014	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	9.39e-06	0.000139	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	9.36e-06	0.000139	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	9.27e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SST—epilepsy syndrome	9.27e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	9.27e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	9.27e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	9.24e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	9.24e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SST—epilepsy syndrome	9.24e-06	0.000137	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	9.19e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	9.16e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SST—epilepsy syndrome	9.15e-06	0.000136	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	9.07e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	9.07e-06	0.000135	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	9.04e-06	0.000134	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	9.04e-06	0.000134	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	9.01e-06	0.000134	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	8.96e-06	0.000133	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	8.92e-06	0.000132	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	8.72e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	8.72e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	8.7e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	8.69e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	8.69e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	8.68e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	8.68e-06	0.000129	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	8.65e-06	0.000128	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	8.64e-06	0.000128	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	8.62e-06	0.000128	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	8.61e-06	0.000128	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	8.61e-06	0.000128	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	8.59e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	8.57e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	8.56e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	8.56e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	8.53e-06	0.000127	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	8.53e-06	0.000126	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	8.53e-06	0.000126	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	8.53e-06	0.000126	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	8.5e-06	0.000126	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—HMOX1—epilepsy syndrome	8.45e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	8.45e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	8.45e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	8.42e-06	0.000125	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	8.35e-06	0.000124	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—CAT—epilepsy syndrome	8.34e-06	0.000124	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	8.32e-06	0.000123	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	8.24e-06	0.000122	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ABCB1—epilepsy syndrome	8.11e-06	0.00012	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	8.1e-06	0.00012	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	8.08e-06	0.00012	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	8e-06	0.000119	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	7.95e-06	0.000118	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	7.93e-06	0.000118	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	7.9e-06	0.000117	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	7.88e-06	0.000117	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	7.85e-06	0.000116	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	7.8e-06	0.000116	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	7.77e-06	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	7.75e-06	0.000115	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	7.73e-06	0.000115	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	7.71e-06	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	7.67e-06	0.000114	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	7.63e-06	0.000113	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—GPX1—epilepsy syndrome	7.54e-06	0.000112	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	7.35e-06	0.000109	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	7.32e-06	0.000109	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	7.28e-06	0.000108	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	7.26e-06	0.000108	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	7.25e-06	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	7.25e-06	0.000108	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	7.23e-06	0.000107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	7.18e-06	0.000107	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	7.16e-06	0.000106	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	7.03e-06	0.000104	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	7e-06	0.000104	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	6.94e-06	0.000103	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	6.64e-06	9.85e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	6.62e-06	9.82e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AGT—epilepsy syndrome	6.61e-06	9.81e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	6.56e-06	9.73e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—APOE—epilepsy syndrome	6.48e-06	9.61e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	6.46e-06	9.58e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	6.44e-06	9.55e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	6.44e-06	9.55e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	6.43e-06	9.53e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	6.42e-06	9.52e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	6.41e-06	9.5e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	6.38e-06	9.46e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	6.36e-06	9.42e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	6.34e-06	9.41e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.21e-06	9.21e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	6.19e-06	9.18e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	6.14e-06	9.11e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	6.13e-06	9.09e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	6.12e-06	9.08e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	6.06e-06	8.99e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	5.97e-06	8.86e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	5.96e-06	8.83e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	5.9e-06	8.75e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	5.85e-06	8.67e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	5.83e-06	8.64e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	5.77e-06	8.56e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—POMC—epilepsy syndrome	5.57e-06	8.25e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	5.55e-06	8.24e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	5.55e-06	8.23e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	5.54e-06	8.21e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	5.53e-06	8.2e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	5.48e-06	8.13e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	5.48e-06	8.12e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	5.44e-06	8.06e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	5.42e-06	8.03e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	5.37e-06	7.96e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	5.33e-06	7.9e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	5.31e-06	7.87e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	5.26e-06	7.8e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	5.13e-06	7.6e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	5.11e-06	7.58e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	5.11e-06	7.57e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	5.09e-06	7.55e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—ALB—epilepsy syndrome	5.08e-06	7.53e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	5.06e-06	7.5e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	5.04e-06	7.47e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	4.67e-06	6.92e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	4.65e-06	6.9e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	4.61e-06	6.84e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	4.57e-06	6.78e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	4.55e-06	6.75e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	4.51e-06	6.69e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—PTGS2—epilepsy syndrome	4.44e-06	6.58e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	4.13e-06	6.12e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	4.12e-06	6.1e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	4.08e-06	6.04e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	3.83e-06	5.68e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	3.82e-06	5.67e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	3.78e-06	5.61e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	3.76e-06	5.57e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	3.75e-06	5.56e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	3.71e-06	5.5e-05	CbGpPWpGaD
Mepenzolate—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.49e-06	5.17e-05	CbGpPWpGaD
Mepenzolate—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	3.48e-06	5.16e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	3.46e-06	5.13e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	3.45e-06	5.11e-05	CbGpPWpGaD
Mepenzolate—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.44e-06	5.11e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	3.41e-06	5.06e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	3.36e-06	4.98e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	3.35e-06	4.96e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	3.31e-06	4.92e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	3.27e-06	4.84e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	3.26e-06	4.83e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	3.23e-06	4.78e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.17e-06	4.7e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	3.16e-06	4.68e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.13e-06	4.64e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	3.01e-06	4.47e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	3e-06	4.45e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	2.97e-06	4.41e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	2.93e-06	4.35e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	2.92e-06	4.34e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	2.9e-06	4.29e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Metabolism—AKT1—epilepsy syndrome	2.23e-06	3.31e-05	CbGpPWpGaD
Mepenzolate—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-06	2.78e-05	CbGpPWpGaD
Mepenzolate—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.87e-06	2.77e-05	CbGpPWpGaD
Mepenzolate—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.85e-06	2.74e-05	CbGpPWpGaD
